Journal of Medicinal Chemistry · 2006 · 52 citations · 15 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryNeuropharmacologyCholinergic PharmacologyCholinergic SignalingEnzyme InhibitionEnzyme-substrate RecognitionLigand BindingLigand-based DesignAcetylcholine PharmacologyAcetylcholine Receptor PharmacologyAcetylcholinesterase FunctionAcetylcholinesterase InhibitorsAcetylcholinesterase TargetsButyrylcholinesterase InhibitionCholinergic Receptor PharmacologyCholinergic Receptor Signaling
We describe herein the development of novel huperzine A-tacrine hybrids characterized by 3-methylbicyclo[3.3.1]non-3-ene scaffolds. These compounds were specifically designed to establish tight interactions, through different binding modes, with the midgorge recognition sites of human acetylcholinesterase (hAChE: Y72, D74) and human butyrylcholinesterase (hBuChE: N68, D70) and their catalytic or peripheral sites. Compounds 5a-c show a markedly improved biological profile relative to tacrine and huperzine A.
15
Luisa Savini, Alessandra Gaeta, Caterina Fattorusso et al. · Journal of Medicinal Chemistry · 2002 · 145 citations · Full text